MAYO CLINIC DEPARTMENT OF NEUROLOGY BIOREPOSITORY

Overview

About this study

The purpose of this study is to establish a repository consisting of clinical information, radiological data, serum, peripheral blood lymphocytes, plasma, cerebrospinal fluid (CSF), urine, stool, DNA and tissue specimens collected from patients with neurological diseases or patients with non-neurological conditions to be used as controls or for future genetic/familial studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males & Females
  • All ages are being enrolled
  • A subject must be able to give informed consent or have an appropriate representative available to do so (LAR).

Exclusion Criteria:

  • Institutionalized (i.e., Federal Medical Prison)
  • Allergy to lidocaine, bupivacaine, and/or epinephrine will exclude from skin punch biopsy only
  • Children without a suspected neurological disease

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/18/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathan Staff, M.D., Ph.D.

Contact us for the latest status

Contact information:

Sarah Clark

(507) 293-7476

Clark.Sarah3@mayo.edu

More information

Publications

Publications are currently not available